Literature DB >> 31266804

Transmembrane insertases and N-glycosylation critically determine synthesis, trafficking, and activity of the nonselective cation channel TRPC6.

Brianna E Talbot1, David H Vandorpe1, Brian R Stotter1,2, Seth L Alper1, Johannes S Schlondorff3.   

Abstract

Transient receptor potential cation channel subfamily C member 6 (TRPC6) is a widely expressed ion channel. Gain-of-function mutations in the human TRPC6 channel cause autosomal-dominant focal segmental glomerulosclerosis, but the molecular components involved in disease development remain unclear. Here, we found that overexpression of gain-of-function TRPC6 channel variants is cytotoxic in cultured cells. Exploiting this phenotype in a genome-wide CRISPR/Cas screen for genes whose inactivation rescues cells from TRPC6-associated cytotoxicity, we identified several proteins essential for TRPC6 protein expression, including the endoplasmic reticulum (ER) membrane protein complex transmembrane insertase. We also identified transmembrane protein 208 (TMEM208), a putative component of a signal recognition particle-independent (SND) ER protein-targeting pathway, as being necessary for expression of TRPC6 and several other ion channels and transporters. TRPC6 expression was also diminished by loss of the previously uncharacterized WD repeat domain 83 opposite strand (WDR83OS), which interacted with both TRPC6 and TMEM208. Additionally enriched among the screen hits were genes involved in N-linked protein glycosylation. Deletion of the mannosyl (α-1,3-)-glycoprotein β-1,2-N-acetylglucosaminyltransferase (MGAT1), necessary for the generation of complex N-linked glycans, abrogated TRPC6 gain-of-function variant-mediated Ca2+ influx and extracellular signal-regulated kinase activation in HEK cells, but failed to diminish cytotoxicity in cultured podocytes. However, mutating the two TRPC6 N-glycosylation sites abrogated the cytotoxicity of mutant TRPC6 and reduced its surface expression. These results expand the targets of TMEM208-mediated ER translocation to include multipass transmembrane proteins and suggest that TRPC6 N-glycosylation plays multiple roles in modulating channel trafficking and activity.
© 2019 Talbot et al.

Entities:  

Keywords:  CRISPR/Cas; N-linked glycosylation; channel activation; endoplasmic reticulum (ER); nonselective cation channel; post-translational modification (PTM); protein translocation; transient receptor potential channels (TRP channels)

Mesh:

Substances:

Year:  2019        PMID: 31266804      PMCID: PMC6709635          DOI: 10.1074/jbc.RA119.008299

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  110 in total

1.  TRPC5 is a regulator of hippocampal neurite length and growth cone morphology.

Authors:  Anna Greka; Betsy Navarro; Elena Oancea; Anne Duggan; David E Clapham
Journal:  Nat Neurosci       Date:  2003-08       Impact factor: 24.884

Review 2.  Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP.

Authors:  D J Beech; K Muraki; R Flemming
Journal:  J Physiol       Date:  2004-07-22       Impact factor: 5.182

Review 3.  TRPC6: physiological function and pathophysiological relevance.

Authors:  Alexander Dietrich; Thomas Gudermann
Journal:  Handb Exp Pharmacol       Date:  2014

4.  Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol.

Authors:  T Hofmann; A G Obukhov; M Schaefer; C Harteneck; T Gudermann; G Schultz
Journal:  Nature       Date:  1999-01-21       Impact factor: 49.962

5.  A PLCγ1-dependent, force-sensitive signaling network in the myogenic constriction of cerebral arteries.

Authors:  Albert L Gonzales; Ying Yang; Michelle N Sullivan; Lindsey Sanders; Fabrice Dabertrand; David C Hill-Eubanks; Mark T Nelson; Scott Earley
Journal:  Sci Signal       Date:  2014-05-27       Impact factor: 8.192

6.  Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats.

Authors:  Wanlu Du; Junbo Huang; Hailan Yao; Kechun Zhou; Bo Duan; Yizheng Wang
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

7.  TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.

Authors:  Naoya Onohara; Motohiro Nishida; Ryuji Inoue; Hiroyuki Kobayashi; Hideki Sumimoto; Yoji Sato; Yasuo Mori; Taku Nagao; Hitoshi Kurose
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

8.  The calcium-conducting ion channel transient receptor potential canonical 6 is involved in macrophage inflammatory protein-2-induced migration of mouse neutrophils.

Authors:  N Damann; G Owsianik; S Li; C Poll; B Nilius
Journal:  Acta Physiol (Oxf)       Date:  2009-01       Impact factor: 6.311

9.  The SND proteins constitute an alternative targeting route to the endoplasmic reticulum.

Authors:  Naama Aviram; Tslil Ast; Elizabeth A Costa; Eric C Arakel; Silvia G Chuartzman; Calvin H Jan; Sarah Haßdenteufel; Johanna Dudek; Martin Jung; Stefan Schorr; Richard Zimmermann; Blanche Schwappach; Jonathan S Weissman; Maya Schuldiner
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

10.  Endocardial TRPC-6 Channels Act as Atrial Mechanosensors and Load-Dependent Modulators of Endocardial/Myocardial Cross-Talk.

Authors:  Vesna Nikolova-Krstevski; Soeren Wagner; Ze Yan Yu; Charles D Cox; Jasmina Cvetkovska; Adam P Hill; Inken G Huttner; Victoria Benson; Andreas A Werdich; Calum MacRae; Michael P Feneley; Oliver Friedrich; Boris Martinac; Diane Fatkin
Journal:  JACC Basic Transl Sci       Date:  2017-10-30
View more
  9 in total

1.  Structural and mechanistic basis of the EMC-dependent biogenesis of distinct transmembrane clients.

Authors:  Lakshmi E Miller-Vedam; Bastian Bräuning; Katerina D Popova; Nicole T Schirle Oakdale; Jessica L Bonnar; Jesuraj R Prabu; Elizabeth A Boydston; Natalia Sevillano; Matthew J Shurtleff; Robert M Stroud; Charles S Craik; Brenda A Schulman; Adam Frost; Jonathan S Weissman
Journal:  Elife       Date:  2020-11-25       Impact factor: 8.140

Review 2.  The mechanisms of integral membrane protein biogenesis.

Authors:  Ramanujan S Hegde; Robert J Keenan
Journal:  Nat Rev Mol Cell Biol       Date:  2021-09-23       Impact factor: 94.444

3.  Mechanism of an intramembrane chaperone for multipass membrane proteins.

Authors:  Luka Smalinskaitė; Min Kyung Kim; Aaron J O Lewis; Robert J Keenan; Ramanujan S Hegde
Journal:  Nature       Date:  2022-10-19       Impact factor: 69.504

4.  The architecture of EMC reveals a path for membrane protein insertion.

Authors:  John P O'Donnell; Ben P Phillips; Yuichi Yagita; Szymon Juszkiewicz; Armin Wagner; Duccio Malinverni; Robert J Keenan; Elizabeth A Miller; Ramanujan S Hegde
Journal:  Elife       Date:  2020-05-27       Impact factor: 8.140

Review 5.  Post-Translational Modification and Natural Mutation of TRPC Channels.

Authors:  Xianji Liu; Xiaoqiang Yao; Suk Ying Tsang
Journal:  Cells       Date:  2020-01-07       Impact factor: 6.600

6.  An ER translocon for multi-pass membrane protein biogenesis.

Authors:  Philip T McGilvray; S Andrei Anghel; Arunkumar Sundaram; Frank Zhong; Michael J Trnka; James R Fuller; Hong Hu; Alma L Burlingame; Robert J Keenan
Journal:  Elife       Date:  2020-08-21       Impact factor: 8.140

Review 7.  The Molecular Biodiversity of Protein Targeting and Protein Transport Related to the Endoplasmic Reticulum.

Authors:  Andrea Tirincsi; Mark Sicking; Drazena Hadzibeganovic; Sarah Haßdenteufel; Sven Lang
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

Review 8.  Signal Peptide Features Determining the Substrate Specificities of Targeting and Translocation Components in Human ER Protein Import.

Authors:  Sven Lang; Duy Nguyen; Pratiti Bhadra; Martin Jung; Volkhard Helms; Richard Zimmermann
Journal:  Front Physiol       Date:  2022-07-11       Impact factor: 4.755

9.  Gain-of-function, focal segmental glomerulosclerosis Trpc6 mutation minimally affects susceptibility to renal injury in several mouse models.

Authors:  Brittney J Brown; Kimber L Boekell; Brian R Stotter; Brianna E Talbot; Johannes S Schlondorff
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.